Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: Renovaro (NASDAQ:RENB), Invizyne Technologies (NASDAQ:IZTC), Monopar Therapeutics (NASDAQ:MNPR), Aligos Therapeutics (NASDAQ:ALGS) and Atossa Therapeutics (NASDAQ:ATOS).
Cabaletta Bio has a consensus price target of $24.00.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $2.409 last updated January 8, 2025 at 7:19 PM EST.
There are no upcoming dividends for Cabaletta Bio.
Cabaletta Bio’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.